Literature DB >> 24327665

Using electronic medical record data to characterize the level of medication use by age-groups in a network of primary care clinics.

Jeff Freund1, Jon Meiman, Connie Kraus.   

Abstract

PURPOSE: Our primary aim was to characterize the level of medication use across age-groups by examining electronic medical record data for a large number of patients receiving care in primary care clinics. A secondary aim was to identify factors associated with higher levels of medication use or polypharmacy.
METHODS: We conducted a retrospective query of electronic medical record data from a clinical data warehouse, evaluating 114 012 patients seen in primary care clinics at least once in the previous 6 months. Medication use was evaluated in 3 different categories: level 1 (0-4 medications), level 2 (5-9 medications), and level 3 (≥ 10 medications). Multivariate analysis was used to analyze different patient demographics and comorbidities for association with level of medication use.
RESULTS: At ages 18 to 24 years, 15% (male) to 23% (female) of patients were taking greater than 5 medications, a trend that continued to increase with older cohorts. Female patients were more likely to have level 2 (odds ratio [OR] = 1.76) and level 3 (OR = 2.73) use compared with men. Level 2 and level 3 use was associated with other patient characteristics, including number of patient encounters (level 2 OR = 2.99; level 3 OR = 8.08 for >7 encounters) and common chronic conditions such as chronic pain (level 2 OR = 2.56; level 3 OR = 6.40), diabetes (level 2 OR = 2.4; level 3 OR = 4.61), heart disease (level 2 OR = 1.99; level 3 OR = 3.65), hypertension (level 2 OR = 2.27; level 3 OR = 2.87), and dyslipidemia (level 2 OR = 1.82; level 3 OR = 2.12).
CONCLUSION: Electronic medical record data may be an important tool for providing more comprehensive information regarding medication usage. Medication usage assessed by electronic medical records, even among the youngest cohort, appears to be greater than other sources of medication usage indicate. Higher levels of medication use were associated with a number of factors, including gender, body mass index, number of patient encounters, and comorbid conditions.

Entities:  

Keywords:  family medicine; medication use; polypharmacy; primary care; sociodemographic characteristics

Mesh:

Year:  2013        PMID: 24327665     DOI: 10.1177/2150131913495243

Source DB:  PubMed          Journal:  J Prim Care Community Health        ISSN: 2150-1319


  5 in total

1.  Overall prescription medication use among adults: findings from the Survey of the Health of Wisconsin.

Authors:  Jianhong Che; Kristen C Malecki; Matthew C Walsh; Andrew J Bersch; Vincent Chan; Christine A McWilliams; F Javier Nieto
Journal:  WMJ       Date:  2014-12

Review 2.  Factors influencing the development of primary care data collection projects from electronic health records: a systematic review of the literature.

Authors:  Marie-Line Gentil; Marc Cuggia; Laure Fiquet; Camille Hagenbourger; Thomas Le Berre; Agnès Banâtre; Eric Renault; Guillaume Bouzille; Anthony Chapron
Journal:  BMC Med Inform Decis Mak       Date:  2017-09-25       Impact factor: 2.796

3.  Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients.

Authors:  Marina Guisado-Clavero; Concepción Violán; Tomàs López-Jimenez; Albert Roso-Llorach; Mariona Pons-Vigués; Miguel Angel Muñoz; Quintí Foguet-Boreu
Journal:  BMC Fam Pract       Date:  2019-06-13       Impact factor: 2.497

4.  Quality of EHR data extractions for studies of preterm birth in a tertiary care center: guidelines for obtaining reliable data.

Authors:  Lindsey A Knake; Monika Ahuja; Erin L McDonald; Kelli K Ryckman; Nancy Weathers; Todd Burstain; John M Dagle; Jeffrey C Murray; Prakash Nadkarni
Journal:  BMC Pediatr       Date:  2016-04-29       Impact factor: 2.125

5.  The impact of frailty on admission to home care services and nursing homes: eight-year follow-up of a community-dwelling, older adult, Spanish cohort.

Authors:  Francisco Cegri; Francesc Orfila; Rosa M Abellana; María Pastor-Valero
Journal:  BMC Geriatr       Date:  2020-08-06       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.